Cargando…
Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
OBJECTIVE: To detect the activation of the EGFR and mTOR signaling pathways in the triple negative breast cancer cell line MDA-MB-468 and investigate the inhibitory effect of gefitinib, an epidermal growth factor receptor inhibitor, and everolimus, a target protein inhibitor of rapamycin, on triple...
Autores principales: | Ma, Jing, Dong, Chao, Cao, Yan-Zhen, Ma, Bin-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864233/ https://www.ncbi.nlm.nih.gov/pubmed/36691572 http://dx.doi.org/10.2147/BCTT.S390017 |
Ejemplares similares
-
Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013) -
EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
por: El Guerrab, Abderrahim, et al.
Publicado: (2020) -
Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)